Related Experiment Video
Updated: Aug 16, 2025

14:23
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
15.7K
Intrahost evolution of the HIV-2 capsid correlates with progression to AIDS
M T Boswell1, J Nazziwa2, K Kuroki3
1Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, OX3 7FZ, Oxford, UK.
Virus Evolution
|December 19, 2022
Summary
Human Immunodeficiency Virus type 2 (HIV-2) p26 capsid evolution is linked to disease progression. Faster evolving HIV-2 p26 sequences correlate with quicker disease advancement and may represent a therapeutic target.
Area of Science:
- Virology
- Immunology
- Evolutionary Biology
Background:
- HIV-2 infection progresses to AIDS slower than HIV-1.
- HIV-2 p26 (capsid) polymorphisms and env evolution are linked to slower disease progression.
- Understanding HIV-2 evolution is crucial for identifying therapeutic targets.
Purpose of the Study:
- To analyze HIV-2 p26 sequence evolution in relation to disease progression.
- To determine if evolutionary parameters of p26 are associated with faster or slower progression to AIDS.
- To identify specific p26 amino acid sites and evolutionary rates linked to disease progression.
Main Methods:
- Analysis of 369 heterochronous HIV-2 p26 sequences from 12 participants.
- Stratification of participants into faster and slower progressor groups based on CD4% change.
- Measurement of p26 sequence diversity, site-specific selection pressures, and evolutionary rates.
Main Results:
- Faster progressors exhibited higher p26 sequence diversity and significantly higher virus evolutionary rates (synonymous and nonsynonymous).
- Virus evolutionary rates negatively correlated with CD4% decline rates.
- Distinct amino acid signatures at p26 positions 6, 12, and 119 were observed between faster and slower progressors, near the TRIM5α/p26 interface.
Conclusions:
- HIV-2 p26 evolutionary rates are associated with AIDS progression, primarily driven by synonymous substitutions.
- Limited nonsynonymous evolution suggests p26 is relatively conserved within hosts.
- HIV-2 p26 represents a potential therapeutic target due to its association with disease progression.
Related Concept Videos
Retrovirus Life Cycles
46.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
Size and Structure of Viral Genomes
98
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
98
Retroviruses
12.6K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Viral Mutations
32.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.7K

